Year: 2023

Artios to Present Initial Phase 1 Clinical Monotherapy Data for ATR Inhibitor ART0380 in Advanced Solid Tumors at the European Society of Medical Oncology Congress 2023

ART0380 is a highly competitive, wholly owned ATR inhibitor with broad clinical application alone or in combination for DDR deficient...

InStride Health, a Specialty Pediatric Anxiety/OCD Outpatient Treatment Provider, Shares Clinically Meaningful Results in First Annual Outcomes Report

InStride Health, in collaboration with McLean Hospital (#1 ranked psychiatric hospital in the US), continues to expand its proven care...

Relatient Announces Inaugural Customer Advisory Board to Accelerate Customer-centric Operations and Innovation

Board members from various backgrounds and specialties will provide feedback and insights to inform real-time organizational prioritiesATLANTA--(BUSINESS WIRE)--#chat--Relatient, the leading...

error: Content is protected !!